Elfi-Tech For Profit

Elfi-Tech is a company that develops non-invasive blood flow monitoring solutions for in-hospital and home care. Their Hemodynamic-Peripheral Flow Patient Monitoring system uses a compact and versatile optical sensor based on miniaturized dynamic light scattering (mDLS) technology and advanced algorithms for multi-parametric detection. The sensor readings are resistant to ambient light and not affected by skin pigmentation. Their proprietary solution measures blood flow and other hemodynamic parameters, opening the door to endless opportunities for new applications. Elfi-Tech's sensing technology is not yet FDA cleared for commercial use, with an expected US launch by 2024. The company has several use cases, including blood circulation and wound healing, fluid management, sepsis, hemodynamic stability, peripheral flow monitoring, and peripheral artery disease. They have strong intellectual property, with 16 patent applications in 5 patent families covering the technology and applications, 13 granted with coverage in the US, EU, and Japan. Elfi-Tech has published 8 publications in peer-reviewed journals, 9 conference papers and posters, 406 citations, and 12 clinical trial sites in the US, EU, and Israel covering multiple mDLS applications. Contact_info: info@elfi-tech.com.

Founded Date: 2006-01-01
Headquarters: Rehovot, HaMerkaz, Israel
Technology: Biomarker panels
Employee Number: 11-50
Industry: Clinical Data Management
Estimated Revenue: $6.3 million
Number Of Exists: N/A
Funding Status: N/A
Investor Type: N/A
Investment Stage: N/A